NaCeF4:Gd,Tb Scintillator as an X-ray Responsive Photosensitizer for Multimodal Imaging-Guided Synchronous Radio/Radiodynamic Therapy
- PMID: 31576757
- DOI: 10.1021/acs.nanolett.9b03682
NaCeF4:Gd,Tb Scintillator as an X-ray Responsive Photosensitizer for Multimodal Imaging-Guided Synchronous Radio/Radiodynamic Therapy
Abstract
Photosensitizers (PSs) that are directly responsive to X-ray for radiodynamic therapy (RDT) with desirable imaging abilities have great potential applications in cancer therapy. Herein, the cerium (Ce)-doped NaCeF4:Gd,Tb scintillating nanoparticle (ScNP or scintillator) is first reported. Due to the sensitization effect of the Ce ions, Tb ions can emit fluorescence under X-ray irradiation to trigger X-ray excited fluorescence (XEF). Moreover, Ce and Tb ions can absorb the energy of secondary electrons generated by X-ray to produce reactive oxide species (ROS) for RDT. With the intrinsic absorption of X-ray by lanthanide elements, the NaCeF4:Gd,Tb ScNPs also act as a computed tomography (CT) imaging contrast agent and radiosensitizers for radiotherapy (RT) sensitization synchronously. Most importantly, the transverse relaxation time of Gd3+ ions is shortened due to the doping of Ce and Tb ions, leading to the excellent performance of our ScNPs in T2-weighted MR imaging for the first time. Both in vitro and in vivo studies verify that our synthesized ScNPs have good performance in XEF, CT, and T2-weighted MR imaging, and a synchronous RT/RDT is achieved with significant suppression on tumor progression under X-ray irradiation. Importantly, no systemic toxicity is observed after intravenous injection of ScNPs. Our work highlights that ScNPs have potential in multimodal imaging-guided RT/RDT of deep tumors.
Keywords: NaCeF4:Gd,Tb scintillator; T2-weighted MR imaging; X-ray excited fluorescence; enhanced radiotherapy; radiodynamic therapy.
Similar articles
-
Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response.Theranostics. 2023 Jan 22;13(3):1042-1058. doi: 10.7150/thno.78649. eCollection 2023. Theranostics. 2023. PMID: 36793856 Free PMC article.
-
Lanthanide-Doped Core-Shell-Shell Nanocomposite for Dual Photodynamic Therapy and Luminescence Imaging by a Single X-ray Excitation Source.ACS Appl Mater Interfaces. 2018 Mar 7;10(9):7859-7870. doi: 10.1021/acsami.8b00015. Epub 2018 Feb 20. ACS Appl Mater Interfaces. 2018. PMID: 29405703
-
Rose Bengal Decorated NaYF4:Tb Nanoparticles for Low Dose X-ray-Induced Photodynamic Therapy in Cancer Cells.ACS Appl Bio Mater. 2022 Nov 21;5(11):5477-5486. doi: 10.1021/acsabm.2c00801. Epub 2022 Nov 1. ACS Appl Bio Mater. 2022. PMID: 36318743
-
Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy.ACS Nano. 2016 Apr 26;10(4):3918-35. doi: 10.1021/acsnano.6b01401. Epub 2016 Apr 8. ACS Nano. 2016. PMID: 27043181 Free PMC article. Review.
-
Nanomaterials for Deep Tumor Treatment.Mini Rev Med Chem. 2021;21(6):677-688. doi: 10.2174/1389557520666201111161705. Mini Rev Med Chem. 2021. PMID: 33176645 Review.
Cited by
-
Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme.J Nanobiotechnology. 2020 Sep 3;18(1):122. doi: 10.1186/s12951-020-00684-5. J Nanobiotechnology. 2020. PMID: 32883290 Free PMC article. Review.
-
PEI functionalized NaCeF4:Tb3+/Eu3+ for photoluminescence sensing of heavy metal ions and explosive aromatic nitro compounds.RSC Adv. 2021 May 27;11(32):19333-19350. doi: 10.1039/d1ra02910j. eCollection 2021 May 27. RSC Adv. 2021. PMID: 35479215 Free PMC article.
-
Nanoparticles augment the therapeutic window of RT and immunotherapy for treating cancers: pivotal role of autophagy.Theranostics. 2023 Jan 1;13(1):40-58. doi: 10.7150/thno.77233. eCollection 2023. Theranostics. 2023. PMID: 36593951 Free PMC article. Review.
-
Current advance of nanotechnology in diagnosis and treatment for malignant tumors.Signal Transduct Target Ther. 2024 Aug 12;9(1):200. doi: 10.1038/s41392-024-01889-y. Signal Transduct Target Ther. 2024. PMID: 39128942 Free PMC article. Review.
-
Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response.Theranostics. 2023 Jan 22;13(3):1042-1058. doi: 10.7150/thno.78649. eCollection 2023. Theranostics. 2023. PMID: 36793856 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical